Latest Listings And Ipos News

Westgold Resources is set to demerge its non-core Reedy and Comet gold projects into a new ASX-listed entity, Valiant Gold, aiming to unlock value and fast-track cash flow through a strategic ore purchase agreement.

Biotron Limited’s BITO securities have been suspended from ASX trading due to non-compliance with key listing rules, raising questions about the company’s next steps.

Mt Malcolm Mines has executed a binding agreement to acquire key components of a 500,000 tonnes per annum gold processing plant, positioning itself for future self-processing and toll-milling opportunities in the prolific Leonora gold region.

Nova Minerals Limited has voluntarily suspended trading of its shares on the ASX pending a capital raising announcement expected on 17 December 2025.

Rent.com.au has locked in up to $5.5 million in growth capital by underwriting the exercise of its remaining listed options, positioning the company for accelerated profitability and expansion of its RentBond® loan book.

Apiam Animal Health Limited shareholders are set to vote on a scheme of arrangement offering $0.87 cash per share or a mix of cash and unlisted scrip in a new holding company controlled by Adamantem Capital. The Independent Expert deems the cash offer fair and reasonable, while scrip options carry liquidity and minority risks.

Assetora Limited has raised $1.535 million through three placements, including a second investment from Creative Capital Management, to advance its alternative-asset platform.

Assetora Limited has updated its previous placement announcements, confirming that the issuance of shares to Cardio Link and Creative Capital Management will now require shareholder approval at an upcoming EGM likely scheduled for late January 2026.

Metal Bank Limited addresses ASX concerns over recent share price volatility, confirming a pending Mineral Resource Estimate announcement and recent strategic moves as key drivers.

NEXTDC has responded to ASX concerns over early media disclosures about its $7 billion OpenAI data centre deal, affirming compliance with continuous disclosure rules and downplaying price sensitivity.

Lycopodium Limited has addressed ASX concerns over delayed director interest disclosures, attributing the lapse to an administrative oversight while reaffirming its compliance policies.

RMA Global Limited has firmly denied allegations of selective disclosure following a December 4 webinar that coincided with a notable share price rise. The company insists no new price sensitive information was shared beyond prior ASX announcements.